The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia
Abstract
Rationale Hyponatremia and dexamethasone resistance in polydipsic schizophrenic patients are attributable to changes in hippocampal-modulated antidiuretic and stress hormone activity, respectively. The relationship of the neuroendocrine findings to the psychiatric illness, however, is unknown. An impaired ability to identify facial emotions has been linked to core features of schizophrenia and to diminished levels of the closely related hormone, oxytocin, in the polydipsic subset. Intranasal oxytocin enhances facial affect discrimination in healthy subjects.Objective The aim of this study is to explore if oxytocin reverses impaired facial affect discrimination in schizophrenic patients with, relative to that in patients without, polydipsia.Methods Intranasal oxytocin (10 or 20 IU) and placebo were administered on three occasions to five polydipsic schizophrenic patients, eight nonpolydipsic patients, and 11 healthy controls. Subsequently, subjects rated the presence and intensity of six facial emotions.Results Emotion recognition fell in both patient groups following 10 IU of oxytocin due to an increased propensity to identify all emotions regardless of whether they were displayed. By contrast, emotion recognition improved following 20 IU in polydipsic relative to nonpolydipsic patients due primarily to divergent effects on the bias to identify fear in nonfearful faces.Conclusion The effects of 20 IU oxytocin support the hypothesis that altered neuroendocrine function in polydipsic patients contributes to their psychiatric illness. Further studies are warranted to confirm these findings and assess if oxytocin treatment improves social functioning in this subset. This is the first psychopharmacologic study to compare different doses of oxytocin in the same subject, thus the significance of the opposing responses is unclear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies that have controlled for dose show important dose-dependent variation on physiology (Cardoso et al., 2013) or social cognition (Goldman et al., 2011; Hall et al., 2012).”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Goldman et al., 2011
In the citing paper
“Middle doses (20–24 IU) have the greatest positive effects, whereas low (10 IU) or high doses (48 IU) show blunted effects (Goldman et al., 2011; Hall et al., 2012; Cardoso et al., 2013).”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Goldman et al., 2011
In the citing paper
“In schizophrenic patients, intranasal OT increased emotion recognition at one dose (20 IU) and decreased emotion recognition at a different dose (10 IU) (23).”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [23]
In the citing paper
“A clinical study with divergent single-dose oxytocin administration in patients with schizophrenia showed that 20 IU oxytocin, but not 10 IU oxytocin, ameliorated emotion recognition deficits in a polydipsic group.18”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [18]
In the citing paper
“Only a few studies examined the differential effects of higher (24, 40 or 48 IU) and lower (10, 20 or 24 IU, respectively) oxytocin doses [103-105].”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
In the citing paper
“In these studies the dose around 20 IU (24 IU or 20 IU) had more favorable effects compared to the other dose studied (48, 40 or 10 IU).”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
In the citing paper
“However, these studies were single administration studies on non-clinical outcome measures.”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
Citations
Cites
Baron‐Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00715 · Cited by 4,555 · cited 1×
“Pictures were a subset from Ekman and Friesen (1976) previously used to demonstrate altered responses in facial affect discrimination in patients with amygdala pathology (Adolphs et al. 1999), autism ( Baron-Cohen et al. 2001 ), and schizophrenia (Addington et al. 2006).”
MethodEkman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Baron‐Cohen, S., Wheelwright, S. J., Hill, J., Raste, Y., & Plumb, I. (2001) · PubMed · Cited by 4,313
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Neuroendocrine perspectives on social attachment and love
Sue Carter, C. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00055-9 · Cited by 1,425
Oxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298
Contributions to Neuropsychological Assessment
Sarazin, F. (1996) · Europe PMC (PubMed Central) · Cited by 1,151
Facial Emotion Perception in Schizophrenia: A Meta-analytic Review
Kohler, C. G., Walker, J. B., Martin, E. A., Healey, K. M., & Moberg, P. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn192 · Cited by 991
Contributions to Neuropsychological Assessment
Greene, J. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.346 · Cited by 825
Research works printed but not linked: 1
- Targowla R (1923) Des troubles fonctionnel du rein dans les maladies mentales. L’excretion del’eau (Kidney malfunction and mental illness: water excretion). Bull Mém Soc Méd Hôp Paris 47:1711–1715
Cited by
Sorted by citations
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
Is oxytocin “nature’s medicine”
Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394
Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.34 · Cited by 383
Shahrestani, S., Kemp, A. H., & Guastella, A. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.86 · Cited by 283
Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267
Metadata
- Authors
- Goldman, M. B., Gomes, A. M., Carter, C. S., & Lee, R.
- Affiliations
- Northwestern University (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Corresponding author
- Goldman, Morris B.
- Venue
- Psychopharmacology
- Published
- 2011-02-09
- Volume
- 216
- Issue
- 1
- Pages
- 101-110
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2071486937
- Cited by
- 112
- References
- 62
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 6 · 2015: 12 · 2014: 24 · 2013: 20 · 2012: 10
- FWCI
- 25.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Institutes of Health
- National Institute of Mental Health (R21MH082295)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Face Recognition and Perception
- Keywords
- intranasal oxytocin, polydipsia, schizophrenia, facial emotion recognition, dose-dependent effects, hyponatremia, dexamethasone resistance, neuroendocrine dysfunction, vasopressin, stress hormones
- MeSH terms
- Administration, Intranasal, Adult, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Facial Expression, Female, Humans, Male, Middle Aged, Oxytocin, Pilot Projects, Schizophrenia, Schizophrenic Psychology, Thirst, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
